A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer. Read more about A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Post-diagnostic health behaviour scores in relation to fatal prostate cancer. Read more about Post-diagnostic health behaviour scores in relation to fatal prostate cancer.
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Read more about Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade. Read more about Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Read more about Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. Read more about Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Read more about New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
Cancer health disparities in racial/ethnic minorities in the United States. Read more about Cancer health disparities in racial/ethnic minorities in the United States.
Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper. Read more about Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. Read more about Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
